Study on Migraine and Headache in Epileptic Patients
NCT00642564 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 955
Last updated 2014-05-23
Summary
The purpose of this study is to collect data from patients who are diagnosed with epilepsy and are followed up in epilepsy clinics.
Conditions
Interventions
- OTHER
-
Observational study in Epileptic Patients
Observation study in Epileptic Patients with Migraine and Headache
Sponsors & Collaborators
-
Johnson & Johnson Taiwan Ltd
lead INDUSTRY
Principal Investigators
-
Johnson & Johnson Taiwan, Ltd. Clinical Trial · Johnson & Johnson Taiwan Ltd
Eligibility
- Min Age
- 7 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2009-03-31
- Completion
- 2009-03-31
More Related Trials
-
Pilot Study for a Machine Learning Test for Migraine
NCT05517200 ·Status: UNKNOWN
-
The Utility of Telemedicine in the Management of Migraine
NCT01706003 ·Status: COMPLETED
-
A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
NCT00236509 ·Status: COMPLETED ·Phase: PHASE3
-
A Feasibility Clinical Trial to Evaluate High Frequency Spinal Cord Stimulation for the Treatment of Patients With Chronic Migraine
NCT01653340 ·Status: COMPLETED ·Phase: NA
-
A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache
NCT02991430 ·Status: TERMINATED ·Phase: NA
-
Middle Meningeal Artery Embolization for Chronic Migraine
NCT07044648 ·Status: WITHDRAWN ·Phase: NA
-
A Study of the Safety and Efficacy of MK-6096 for Migraine Prophylaxis in Participants With Episodic Migraine (MK-6096-020)
NCT01513291 ·Status: COMPLETED ·Phase: PHASE2
-
Ketone for Migraine Prevention
NCT05085483 ·Status: COMPLETED ·Phase: NA
-
Migraine in Adolescents
NCT05654012 ·Status: RECRUITING ·Phase: NA
-
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
NCT05164172 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Stellate Ganglion Block With Lidocaine Combined Platelet-rich Plasma to Treat Chronic Migraine
NCT06653218 ·Status: COMPLETED
-
Repetitive Transcranial Magnetic Stimulation in Treatment and Prophylaxis of Chronic Migraine in Patients With no Prophylactic Treatment for the Last 3 Months
NCT06461767 ·Status: RECRUITING ·Phase: NA
-
The Efficacy of Beneficial Intestinal Microbiota in the Treatment of Migraine and Its Mechanism: Basic and Clinical Studies
NCT07092241 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.
NCT03083860 ·Status: UNKNOWN ·Phase: NA
-
Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.
NCT04698525 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan
NCT05064371 ·Status: COMPLETED ·Phase: PHASE3
-
Greater Occipital Nerve Blockade and Sphenopalatine Ganglion Blockade in Patients With Episodic Migraine
NCT06997562 ·Status: COMPLETED ·Phase: NA
-
A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache
NCT01899040 ·Status: COMPLETED ·Phase: NA
-
Neurostimulation Device for Treatment of Migraine Headache
NCT01630044 ·Status: COMPLETED ·Phase: NA
-
A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age
NCT04464707 ·Status: COMPLETED ·Phase: PHASE3
-
Searching for Novel Biological Phenotypes in Migraine Patients Resistant to Treatments
NCT06562413 ·Status: RECRUITING
-
Research Study Examining Nerve Block for Migraine
NCT00203346 ·Status: COMPLETED
-
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
NCT04965675 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Middle Meningeal Artery Embolization for Treatment of Intractable Migraine
NCT06029153 ·Status: COMPLETED ·Phase: NA
-
A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine
NCT02959190 ·Status: COMPLETED ·Phase: PHASE3